Risks stratification and benefits of PCI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com, -kfeeney@perfuse.org +kfeeney@elon.edu) |
||
| Line 2: | Line 2: | ||
{{SI}} | {{SI}} | ||
'''Editor(s)-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto: | '''Editor(s)-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond) | ||
==Risk Score Assessment== | ==Risk Score Assessment== | ||
Revision as of 20:28, 1 November 2012
Editor(s)-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond)